Strengths of the current investigation include a comprehensively evaluated and broadly representative sample of older adults with plasma p-tau217 levels and ApoE ε4 genotyping, enabling comparison on tests measuring important cognitive markers relevant to prodromal AD namely PSI, frPSI, and SIEs. This evidence concerns the gene APOE and Alzheimer disease.